Surface coating of bone marrow cells with N-acetylglucosamine for bone marrow implantation therapy

Satoshi Kobayashi, Hirohiko Ise, Masafumi Takahashi, Mitsuaki Goto, Toshihiro Akaike, Uichi Ikeda

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Bone marrow implantation (BMI) has been performed clinically for the treatment of ischemic cardiovascular diseases. To achieve BMI effectively, accumulation of many bone marrow cells (BMCs) in an infarcted area of the myocardium is important. Previously, we reported that cardiomyocytes show strong interaction with N-acetylglucosamine (GlcNAc) and they can take up GlcNAc-conjugated liposomes. Thus, we examined whether GlcNAc-coated BMCs exhibit strong interaction with cardiomyocytes. The cell surface of BMCs was coated with GlcNAc without causing cell injury by GlcNAc-lipophilic polymers. It was found that the GlcNAc-coated BMCs exhibited strong interaction with cardiomyocytes. At 7 days of coculturing the GlcNAc-coated BMCs with cardiomyocytes, BMC-derived cardiomyocytes were generated. The number of BMC-derived cardiomyocytes was higher following coculture with GlcNAc-coated BMCs than following coculture with uncoated and maltose (MA)-coated BMCs. In this study, we demonstrated that the surface coating of BMCs with GlcNAc can be performed easily by using GlcNAc-lipophilic polymers and that GlcNAc-coated BMCs exhibited strong interaction with cardiomyocytes. Therefore, we think that cell surface coating with GlcNAc would help promote accumulation of BMCs in the infarcted area of the myocardium and that this accumulation would be helpful in the treatment of ischemic cardiovascular diseases with BMI.

Original languageEnglish
Pages (from-to)574-582
Number of pages9
JournalBiomaterials
Volume30
Issue number4
DOIs
Publication statusPublished - Feb 1 2009
Externally publishedYes

Fingerprint

Acetylglucosamine
Bone Marrow Cells
Bone
Bone Marrow
Cells
Coatings
Cardiac Myocytes
Therapeutics
Coculture Techniques
Myocardium
Polymers
Cardiovascular Diseases
Maltose
Liposomes

All Science Journal Classification (ASJC) codes

  • Bioengineering
  • Ceramics and Composites
  • Biophysics
  • Biomaterials
  • Mechanics of Materials

Cite this

Surface coating of bone marrow cells with N-acetylglucosamine for bone marrow implantation therapy. / Kobayashi, Satoshi; Ise, Hirohiko; Takahashi, Masafumi; Goto, Mitsuaki; Akaike, Toshihiro; Ikeda, Uichi.

In: Biomaterials, Vol. 30, No. 4, 01.02.2009, p. 574-582.

Research output: Contribution to journalArticle

Kobayashi, Satoshi ; Ise, Hirohiko ; Takahashi, Masafumi ; Goto, Mitsuaki ; Akaike, Toshihiro ; Ikeda, Uichi. / Surface coating of bone marrow cells with N-acetylglucosamine for bone marrow implantation therapy. In: Biomaterials. 2009 ; Vol. 30, No. 4. pp. 574-582.
@article{2156096a141b486aa0da99da22b3d6c3,
title = "Surface coating of bone marrow cells with N-acetylglucosamine for bone marrow implantation therapy",
abstract = "Bone marrow implantation (BMI) has been performed clinically for the treatment of ischemic cardiovascular diseases. To achieve BMI effectively, accumulation of many bone marrow cells (BMCs) in an infarcted area of the myocardium is important. Previously, we reported that cardiomyocytes show strong interaction with N-acetylglucosamine (GlcNAc) and they can take up GlcNAc-conjugated liposomes. Thus, we examined whether GlcNAc-coated BMCs exhibit strong interaction with cardiomyocytes. The cell surface of BMCs was coated with GlcNAc without causing cell injury by GlcNAc-lipophilic polymers. It was found that the GlcNAc-coated BMCs exhibited strong interaction with cardiomyocytes. At 7 days of coculturing the GlcNAc-coated BMCs with cardiomyocytes, BMC-derived cardiomyocytes were generated. The number of BMC-derived cardiomyocytes was higher following coculture with GlcNAc-coated BMCs than following coculture with uncoated and maltose (MA)-coated BMCs. In this study, we demonstrated that the surface coating of BMCs with GlcNAc can be performed easily by using GlcNAc-lipophilic polymers and that GlcNAc-coated BMCs exhibited strong interaction with cardiomyocytes. Therefore, we think that cell surface coating with GlcNAc would help promote accumulation of BMCs in the infarcted area of the myocardium and that this accumulation would be helpful in the treatment of ischemic cardiovascular diseases with BMI.",
author = "Satoshi Kobayashi and Hirohiko Ise and Masafumi Takahashi and Mitsuaki Goto and Toshihiro Akaike and Uichi Ikeda",
year = "2009",
month = "2",
day = "1",
doi = "10.1016/j.biomaterials.2008.10.002",
language = "English",
volume = "30",
pages = "574--582",
journal = "Biomaterials",
issn = "0142-9612",
publisher = "Elsevier BV",
number = "4",

}

TY - JOUR

T1 - Surface coating of bone marrow cells with N-acetylglucosamine for bone marrow implantation therapy

AU - Kobayashi, Satoshi

AU - Ise, Hirohiko

AU - Takahashi, Masafumi

AU - Goto, Mitsuaki

AU - Akaike, Toshihiro

AU - Ikeda, Uichi

PY - 2009/2/1

Y1 - 2009/2/1

N2 - Bone marrow implantation (BMI) has been performed clinically for the treatment of ischemic cardiovascular diseases. To achieve BMI effectively, accumulation of many bone marrow cells (BMCs) in an infarcted area of the myocardium is important. Previously, we reported that cardiomyocytes show strong interaction with N-acetylglucosamine (GlcNAc) and they can take up GlcNAc-conjugated liposomes. Thus, we examined whether GlcNAc-coated BMCs exhibit strong interaction with cardiomyocytes. The cell surface of BMCs was coated with GlcNAc without causing cell injury by GlcNAc-lipophilic polymers. It was found that the GlcNAc-coated BMCs exhibited strong interaction with cardiomyocytes. At 7 days of coculturing the GlcNAc-coated BMCs with cardiomyocytes, BMC-derived cardiomyocytes were generated. The number of BMC-derived cardiomyocytes was higher following coculture with GlcNAc-coated BMCs than following coculture with uncoated and maltose (MA)-coated BMCs. In this study, we demonstrated that the surface coating of BMCs with GlcNAc can be performed easily by using GlcNAc-lipophilic polymers and that GlcNAc-coated BMCs exhibited strong interaction with cardiomyocytes. Therefore, we think that cell surface coating with GlcNAc would help promote accumulation of BMCs in the infarcted area of the myocardium and that this accumulation would be helpful in the treatment of ischemic cardiovascular diseases with BMI.

AB - Bone marrow implantation (BMI) has been performed clinically for the treatment of ischemic cardiovascular diseases. To achieve BMI effectively, accumulation of many bone marrow cells (BMCs) in an infarcted area of the myocardium is important. Previously, we reported that cardiomyocytes show strong interaction with N-acetylglucosamine (GlcNAc) and they can take up GlcNAc-conjugated liposomes. Thus, we examined whether GlcNAc-coated BMCs exhibit strong interaction with cardiomyocytes. The cell surface of BMCs was coated with GlcNAc without causing cell injury by GlcNAc-lipophilic polymers. It was found that the GlcNAc-coated BMCs exhibited strong interaction with cardiomyocytes. At 7 days of coculturing the GlcNAc-coated BMCs with cardiomyocytes, BMC-derived cardiomyocytes were generated. The number of BMC-derived cardiomyocytes was higher following coculture with GlcNAc-coated BMCs than following coculture with uncoated and maltose (MA)-coated BMCs. In this study, we demonstrated that the surface coating of BMCs with GlcNAc can be performed easily by using GlcNAc-lipophilic polymers and that GlcNAc-coated BMCs exhibited strong interaction with cardiomyocytes. Therefore, we think that cell surface coating with GlcNAc would help promote accumulation of BMCs in the infarcted area of the myocardium and that this accumulation would be helpful in the treatment of ischemic cardiovascular diseases with BMI.

UR - http://www.scopus.com/inward/record.url?scp=56449086345&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=56449086345&partnerID=8YFLogxK

U2 - 10.1016/j.biomaterials.2008.10.002

DO - 10.1016/j.biomaterials.2008.10.002

M3 - Article

C2 - 18992937

AN - SCOPUS:56449086345

VL - 30

SP - 574

EP - 582

JO - Biomaterials

JF - Biomaterials

SN - 0142-9612

IS - 4

ER -